No.  | API Product  | CAS No  | DMF/CEP  | Standard  | Indication  | 
1  | Benazepril HCl 盐酸贝那普利  | 86541-74-4  | NMPA DMF: Y20190002852 DMF: 033744 CEP:2015-322 CDSCO RC/BD-002644  | USP/EP/Ch.P.  | Cardiovascular  | 
2  | Tirofiban HCl 盐酸替罗非班  | 150915-40-5  | NMPA DMF: Y20190006974 DMF: 032701 EU/ASMF/00701  | In-house  | Cardiovascular  | 
3  | Dronedarone HCl 盐酸决奈达隆  | 141625-93-6  | NMPA DMF:Y20220000297 DMF: 037247 CEP: 2022-277  | USP/EP/Ch.P.  | Cardiovascular  | 
4  | Eribulin Mesylate 甲磺酸艾立布林  | 441045-17-6  | DMF:035523 EU/ASMF/00569  | JP  | Anti-Cancer  | 
5  | Ibrutinib(Form A&C) 伊布替尼  | 936563-96-1  | NMPA DMF: Y20230000804 DMF:038919 DMF:031917  | In-house  | Anti-Cancer  | 
6  | Alogliptin Benzoate 苯甲酸阿格列汀  | 850649-62-6  | NMPA DMF: Y20230001355 DMF:039984  | In-house  | Diabetes  | 
7  | Fosaprepitant Dimeglumine 福沙匹坦双葡甲胺  | 265121-04-8  | NMPA DMF: Y20200001493 DMF:035766 JP MF:304MF10040  | In-house  | Anti-Cancer  | 
8  | Aprepitant 阿瑞匹坦  | 170729-80-3  | NMPA DMF: Y20200000221 DMF:033175 CEP:2019-117 JP MF:230MF10074  | USP/EP  | Anti-Cancer  | 
9  | Dapagliflozin 达格列净  | 960404-48-2  | NMPA DMF: Y20220000848  | In-house  | Diabetes  | 
10  | Entecavir 恩替卡韦  | 209216-23-9  | NMPA DMF: Y20170000425 DMF:033104 CEP:2018-006  | EP/USP  | Anti-Virus  | 
11  | Gefitinib 吉非替尼  | 184475-35-2  | NMPA DMF: Y20200001369 CEP: 2022-291  | EP  | Anti-Cancer  | 
12  | Linagliptin 利格列汀  | 668270-12-0  | DMF:031294  | In-house  | Diabetes  | 
13  | Fasudil HCl 盐酸法舒地尔  | 105628-07-7  | NMPA DMF: Y20220000495 JP MF:231MF10048  | Ch.P./JP  | Cardiovascular  | 
14  | Flurbiprofen Axetil 氟比洛芬酯  | 91503-79-6  | NMPA DMF: Y20220000095  | In-house  | Analgesic  | 
No.  | API Product  | CAS No  | DMF/CEP  | Standard  | Indication  | 
15  | Difelikefalin Acetate 醋酸地非法林  | 1024829-44-4  | Validated  | In-house  | Antipruritic  | 
16  | Linaclotide 利那洛肽  | 851199-59-2  | In progress  | In-house  | IBS-C  | 
17  | Tirzepatide 替尔泊肽  | 2023788-19-2  | In progress  | In-house  | Diabetes  | 
18  | Etelcalcetide HCl 盐酸依特卡肽  | 1334237-71-6  | In progress  | In-house  | SHPT  | 
19  | Semaglutide 司美格鲁肽  | 910463-68-2  | In progress  | In-house  | Diabetes  | 
No.  | API Product  | CAS No  | DMF/CEP  | Standard  | Indication  | 
20  | Trabectedin 曲贝替定  | 114899-77-3  | In progress  | In-house  | Anti-Cancer  | 
21  | Lurbinectedin 芦比替定  | 497871-47-3  | DMF:037624  | In-house  | Anti-Cancer  | 
22  | Baricitinib 巴瑞替尼  | 1187594-09-7  | DMF:036732  | In-house  | Rheumatoid Arthritis  | 
23  | Carfilzomib 卡非佐米  | 868540-17-4  | In progress  | In-house  | Anti-Cancer  | 
24  | Pralsetinib 普拉替尼  | 2097132-94-8  | In progress  | In-house  | Anti-Cancer  | 
25  | Exatecan Mesylate 甲磺酸依喜替康  | 169869-90-3  | In progress  | In-house  | Anti-Cancer  | 
26  | Landiolol HCl 盐酸兰地洛尔  | 144481-98-1  | In progress  | In-house  | Cardiovascular  | 
27  | Pentoxifylline 己酮可可碱  | 6493-05-6  | In progress  | In-house  | Cardiovascular  | 
28  | Ozanimod HCl 盐酸奥扎莫德  | 1618636-37-5  | In progress  | In-house  | Multiple Sclerosis  | 
29  | Enoxaparin Sodium 依诺肝素钠  | 679809-58-6  | In progress  | In-house  | Cardiovascular  | 
30  | Dalteparin Sodium 达肝素钠  | 9041-08-1  | In progress  | In-house  | Cardiovascular  | 
31  | Nadroparin Calcium 那屈肝素钙  | 37270-89-6  | In progress  | In-house  | Cardiovascular  | 
32  | Parnaparin Sodium 帕肝素钠  | 9041-08-1  | In progress  | In-house  | Cardiovascular  | 
33  | Reviparin sodium 瑞肝素钠  | 9005-49-6  | In progress  | In-house  | Cardiovascular  | 
34  | Bemiparin Sodium 贝米肝素钠  | 9041-08-1  | In progress  | In-house  | Cardiovascular  | 
35  | Fondaparinux Sodium 磺达肝癸钠  | 114870-03-0  | DMF:037499  | In-house  | Cardiovascular  |